Glucose As an Energy Source to Increase Self-control in Restrained Eaters (open access)

Glucose As an Energy Source to Increase Self-control in Restrained Eaters

Research evidence is suggestive of a strength model of self-control, also known as ego depletion, in social psychological literature. Engaging in an initial task of self-control depletes a limited resource, resulting in less self-control on a subsequent, unrelated task. The strength model of self-control has been applied to many practical, everyday situations, such as eating behaviors among dieters. Newer studies suggest that blood glucose is the resource consumed during acts of self-control. Consuming glucose seems to "replete" individuals who have been depleted, improving performance and self-control. The current study aimed to examine the effects of ego-depletion on restrained eaters. The hypothesis was that restrained eaters who were depleted by a task of self-control would exhibit more disinhibition on a taste-test task than would restrained eaters who were not depleted. However, if the participants were given glucose following the depletion task, then their self-control would be "repleted" and they would exhibit similar control to that of the non-depleted participants. Contrary to expectations there were no differences between the groups in terms of total amount of cookies consumed. These results are inconsistent with a glucose model of self-control. Suggestions for future research and implications of the findings are discussed.
Date: August 2013
Creator: Valentine, Lisa M.
System: The UNT Digital Library
Personality Factors and Trust in Placebo Medical Trials (open access)

Personality Factors and Trust in Placebo Medical Trials

Prior research has reported that individual differences influence both placebo and nocebo responses. The present study examined how individual personality, as well as trust, influence placebo/nocebo belief and symptom reporting after receiving an inert capsule that for some was described as an active “cognitively-enhancing” trial medication. Individuals (N = 104) were randomly assigned to one of three conditions: condition A participants were told they’d received the medication, condition B participants were told they’d received a placebo, and condition C participants were told, via random assignment, each would receive either the medication or placebo (after the experiment this condition listed the group – medication or placebo - each believed s/he was in). The study was completed in the UNT Student Health and Wellness Center to provide context in a medical setting. Of the 104 participants, 46 (44.2%) were either placed by experimental design or self-report in the medication group. Participants with a belief in medication ingestion, regardless of condition (i.e., A or C), reported significantly more symptoms (M = 16.65, SD = 3.178), than participants who believed they had ingested a placebo (M = 14.21, SD = 2.58), t (102) = 4.32, p = .001. Aspects of Neuroticism and Extroversion, as …
Date: August 2013
Creator: Baker, Brandon Wade Roger
System: The UNT Digital Library
Development of a Differential Neurocognitive Profile for Alzheimer’s Dementia and Vascular Dementia (open access)

Development of a Differential Neurocognitive Profile for Alzheimer’s Dementia and Vascular Dementia

Alzheimer’s Dementia (AD) is among the most common diseases in the Geriatric population, and its prevalence is expected to quadruple by 2047.Vascular Dementia (VaD) is the second most frequent cause of dementia, with studies indicating VaD accounts for 10-20% of dementia cases across the globe. A diagnostic model differentiating AD and VaD would be clinically and scientifically valuable, considering the treatment approaches for these conditions are different. Although there are differences between AD and VaD on their neuropsychological profiles, a diagnostic model that successfully differentiates AD and VaD on neuropsychological testing has not been developed, despite previous attempts. Our study addresses this gap in the literature by examining two diagnostic models used to predict the conversion of AD from mild cognitive impairment, and a third model was proposed to differentiate AD from VaD. We conducted ROC Analyses using the variables LM II Standard Score, Animals Total, and CDRS Sum based on a previous diagnostic model. The sensitivity and specificity for the diagnosis of mild VaD were calculated for all possible scores of each test measure. The Animals Total cutoff score of 7 achieved excellent sensitivity and specificity, receiving 96% and 92%, respectively. In this sample, patients who could name at …
Date: August 2013
Creator: Hill, Jonathan
System: The UNT Digital Library